有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
圖像來源，AFP via Getty Images。关于这个话题，搜狗输入法2026提供了深入分析
15+ Premium newsletters by leading experts，详情可参考safew官方版本下载
The identification of ‘boosters’ that drive gene overexpression directly in a CAR construct provides a simple and scalable strategy for developing effective CAR-NK cell therapies for solid tumours.。关于这个话题，爱思助手下载最新版本提供了深入分析
3. You want a better-performing smartphone The new Qualcomm Snapdragon 8 Gen 5 Elite chipset has already set benchmark records compared with previous versions, and we expect it to outperform Google's Tensor G5 in general performance and power management. This goes hand in hand with Samsung's upgraded 60W wired charging rate, which lets the S26 Ultra top up from 0 to 75% in half an hour.